SAB Biotherapeutics Inc (SABS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.13
• Market Cap: $178.05M
• EPS: $-1.56
• 52-Week High: $4.68
• 52-Week Low: $1.00

Market Sentiment

SAB Biotherapeutics Inc currently has a Bullish sentiment score of 0.33.

About SAB Biotherapeutics Inc

SAB Biotherapeutics Inc. is an innovative biopharmaceutical company focused on developing advanced immunotherapies targeting infectious diseases, autoimmune disorders, and oncology. Headquartered in Sioux Falls, South Dakota, with a strategic office in Cambridge, Massachusetts, the company leverages its proprietary technology platform to create therapeutic antibodies derived from genetically engineered cows. These uniquely produced antibodies aim to provide groundbreaking solutions in areas w...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for SAB Biotherapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SABS pay dividends?

SAB Biotherapeutics Inc (SABS) does not currently pay a regular dividend.

What is SABS's market cap?

SAB Biotherapeutics Inc (SABS) has a market capitalization of $178.05M with a current stock price of $4.13.